Health Condition 1: L80-L99- Other disorders of the skin and subcutaneous tissue
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patient who have not taken treatment before for acanthosis nigricans Patients with lesions in the neck
Exclusion criteria
Exclusion criteria: Patients who are not willing for the study Pregnancy Patients who are currently on topical or systemic treatment for acanthosis nigricans Patients who are on treatment with topical or systemic retinods Patients on treatment with metformin Patient with lesions in regions other than the neck
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To study the efficacy and effectiveness of topical 0.05% tretinoin cream and compare its efficacy with the combination of canthex and topical 0.05% tretinoin cream in the treatment of acanthosis nigricansTimepoint: 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| To determine the safety and side effects of topical tretinoin cream and canthex in patients with acanthosis nigricansTimepoint: 12 weeks | — |
Countries
India
Contacts
SRM Institute of science and technology